TP53 and neoplasm: Our predictions of tumor zygosity are concordant with the roles these genes play: TP53 and RB1 were to determined have >90% of mutations under LOH, while BRAF V600 and KRAS G12 mutations showed no significant enrichment for LOH (Table 3).